Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR

ClinicalTrials.gov ID: NCT01880840

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01880840. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 21, 2026, 11:36 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Trial of the Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With Allergic Rhinitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety of 2 different doses of the investigational use of an allergy medication (Astepro Nasal Spray) in the treatment of allergic rhinitis (AR). This is an open-label study; that is, parent and child will know which group each is in.

Study identification

NCT ID
NCT01880840
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Meda Pharmaceuticals
Industry
Enrollment
191 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Months to 5 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2013 (Type not available)
Primary completion
Apr 2014 (Actual)
Completion
Aug 2014 (Actual)
Last update posted
Jun 29, 2015

2013 – 2014

United States locations

U.S. sites
14
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Clinical Research Center of Alabama,LLC Birmingham Alabama 35209 —
Little Rock Allergy and Asthma Clinical research Center Little Rock Alaska 72205 —
West Coast Clinical Trials Costa Mesa California 92626 —
Southern California Research Mission Viejo California 92691 —
Storms Clinical Research Institute Colorado Springs Colorado 80907 —
Sneeze, Wheeze and Itch Associates Normal Illinois 61761 —
Allergy, Asthma & Clinical Research Center Oklahoma City Oklahoma 73120 —
National Allergy, Asthna & Urticaria Centers of Charleston Pa Charleston Pennsylvania 29406 —
Texas Allergy Research Center Dallas Texas 75246 —
Central Texas Health Research New Braunfels Texas 78130 —
Paul H Ratner,MD San Antonio Texas 78229 —
Live Oak Allergy and Asthma Clinic San Antonio Texas 78233 —
Allergy and Asthma Center Waco Texas 76712 —
Pediatric Allergy,Asthma and Immunology/Allergy& Asthma care of Waco Waco Texas 76712 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01880840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 29, 2015 · Synced Nov 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.